Recruiting

NCT Number: NCT05584293

DIABASE; Diabetes Mellitus Registry in Second Care

This study aims to examine real world data from medical devices and clinical outcome from diabetes mellitus patients to gain the necessary insights to be able to improve individual patient care by building a registry.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ziekenhuisgroep Twente

Almelo, Overijssel, 7609PP, Netherlands

Location status: Recruiting

Location contact

Goos Laverman, prof. dr.

CONTACT

[email protected]

+31887083079

Goos Laverman, prof. dr.

PRINCIPAL_INVESTIGATOR

Thomas Urgert, MSc

CONTACT

[email protected]

+31887083236

Thomas Urgert, MSc

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with type 1 or type 2 diabetes
Patients aged 18 years or older
Patients visiting the outpatient clinic internal medicine in the ZGT Hospital
Written informed consent

Exclusion criteria

Severe general diseases or mental disorders making the participation in the study impossible

Treatment and study plan

Primary outcomes

Real world data from medical devices and clinical outcome in a registry

Time frame: 0-30 years

Examine real world data from medical devices and clinical outcome in a registry to gain the necessary insights to be able to improve individual patient care

Study contacts

Contact information is provided by the study sponsor or research team.

Thomas Urgert, MSc

CONTACT

[email protected]

+31887083236

Sponsors and collaborators

Lead sponsor

Ziekenhuisgroep Twente

Other

Collaborators

University of Twente

Registry information

Acronym: DIABASE

Important dates

Study start: 2020
Primary completion: 2050
Study completion: 2060
First posted: Oct 18, 2022
Registry last updated: Apr 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting